Human dopamine transporter (DAT) 5’UTR epigenetic changes and serum antibodies can be further used to confirm ADHD diagnosis and/or to predict the efficacy of treatment (76). This evidence concerns the gene SLC6A3 and attention deficit-hyperactivity disorder.